A Rising Cluster of Erythropoietin‐Associated Pure Red Cell Aplasia and Subsequent Response to Roxadustat: A Case Series
Nephrology · 2026
DOI: 10.1111/nep.70169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology, 2026. Verfasst von Jayana Devathasan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Waikato Hospital, Hamilton, New Zealand. Hauptthemen laut MEDLINE: Anemia, Epoetin Alfa, Erythropoietin, Hematinics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Patients with chronic kidney disease (CKD) develop anaemia in the setting of abnormal iron metabolism and reduced endogenous erythropoietin. Pure red cell aplasia (PRCA) is a condition that, in rare cases, has been associated with erythropoietin products, commonly prescribed in patients with CKD‐related anaemia. We describe 14 cases of Epoetin‐alfa associated PRCA which have resulted in significant morbidity. Our cases were predominantly male (71%) with a median age of onset 68 years old. Each presented with profound anaemia 4–48 months (median 9.5 months) after commencing subcutaneous Epoetin. Heterogeneous immunosuppression regimens were used, predominantly with either monotherapy prednisone or ciclosporin. Two patients did not receive immunosuppression. Of our 14 cases, eight have since been commenced and maintained on Roxadustat with six of these subsequently reaching target haemoglobin. Of the six not commenced on Roxadustat, only one has reached target haemoglobin. This is the first multi‐patient report of Roxadustat in patients with ESA‐PRCA. Our cluster of cases highlights the need for strong suspicion of acquired PRCA in patients treated with erythropoietin products who present with refractory anaemia. HIF stabilisers such as Roxadustat, which have otherwise not been licensed in New Zealand, seem to be beneficial in these cases, possibly minimising the need for heavy immunosuppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Waikato Hospital, Hamilton, New Zealand.
- Department of Nephrology, Auckland City Hospital, Auckland, New Zealand.
- Department of Nephrology, Middlemore Hospital, Auckland, New Zealand.
- Department of Nephrology, Tauranga Hospital, Tauranga, New Zealand.
- Department of Nephrology, North Shore Hospital, Auckland, New Zealand.
Zitieren
APA
Devathasan, J., Goh, T. L., Lin, D. C., Germann, R., Ly, E., & Singh, G. B. (2026). A Rising Cluster of Erythropoietin‐Associated Pure Red Cell Aplasia and Subsequent Response to Roxadustat: A Case Series. Nephrology. https://doi.org/10.1111/nep.70169
Vancouver
Devathasan J, Goh TL, Lin DC, Germann R, Ly E, Singh GB. A Rising Cluster of Erythropoietin‐Associated Pure Red Cell Aplasia and Subsequent Response to Roxadustat: A Case Series. Nephrology. 2026. doi:10.1111/nep.70169
BibTeX
@article{Devathasan2026,
author = {Devathasan, Jayana and Goh, Tze Liang and Lin, Daniel Chou-Yen and Germann, Richard and Ly, Elene and Singh, Gillian Balbir},
title = {A Rising Cluster of Erythropoietin‐Associated Pure Red Cell Aplasia and Subsequent Response to Roxadustat: A Case Series},
journal = {Nephrology},
year = {2026},
doi = {10.1111/nep.70169}
}
EUVIMED